neostigmine methylsulfate
NDC 31722-994, neostigmine methylsulfate, injection, from Camber Pharmaceuticals Inc..
- Product NDC
- 31722-994
- Status
- Listed
- Labeler
- Camber Pharmaceuticals Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212512
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-994 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEOSTIGMINE METHYLSULFATE.5 mg/mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-994-31 | 31722099431 | 10 VIAL, MULTI-DOSE in 1 CARTON (31722-994-31) / 10 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/d07ff23f-54a5-4036-8005-a3515d4e2194
Use it
Look up 31722-994 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-994 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-994. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.